Literature DB >> 17117128

A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial.

Shu-Min Lin1, Chien-Da Huang, Horng-Chyuan Lin, Chien-Ying Liu, Chun-Hua Wang, Han-Pin Kuo.   

Abstract

We evaluated whether a goal-directed protocol, without measurement of central venous oxygen saturation, would improve survival in medical intensive care unit (ICU) patients with septic shock. This is a prospective, controlled study in a 24-bed medical ICU at a tertiary care hospital. From a total of 241 consecutive patients with septic shock, 224 were randomly assigned to receive therapy with or without a written protocol using central venous pressure, mean arterial pressure, and urine output as therapeutic goals. Baseline characteristics were similar between groups. Implementation of goal-directed therapy caused a more rapid reversal of persistent shock (47 +/- 22.8 vs. 65.4 +/- 32.1 h, P = 0.006) and decreases of ICU (50% vs. 67.2%, P = 0.009) and in-hospital (53.7% vs. 71.6%, P = 0.006) mortality rates compared with non-goal-directed therapy. Patients receiving goal-directed therapy also had less risk for developing central nervous system or renal failure than patients without. Patients with goal-directed therapy received more fluid during the period of persistent shock (136.2 +/- 119 vs. 88.6 +/- 57.7 mL h, P = 0.034) and less delay in vasopressor administration (78 +/- 22.2 vs. 104.4 +/- 29 min, P = 0.001) than patients with non-goal therapy. Implementation of a goal-directed protocol improves survival and clinical outcomes in ICU patients with septic shock. These benefits may arise from adequate fluid resuscitation, earlier vasopressor administration, rapid shock reversal, and protection of major organ function. With central venous oxygen saturation measurement to detect tissue perfusion, the clinical outcomes may be further improved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117128     DOI: 10.1097/01.shk.0000232271.09440.8f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  66 in total

1.  The Surviving Sepsis Campaign's Revised Sepsis Bundles.

Authors:  Amisha V Barochia; Xizhong Cui; Peter Q Eichacker
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

2.  Factors associated with nonadherence to early goal-directed therapy in the ED.

Authors:  Mark E Mikkelsen; David F Gaieski; Munish Goyal; Andrea N Miltiades; Jeffrey C Munson; Jesse M Pines; Barry D Fuchs; Chirag V Shah; Scarlett L Bellamy; Jason D Christie
Journal:  Chest       Date:  2010-02-19       Impact factor: 9.410

3.  Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study.

Authors:  Hiroshi Sekiguchi; Yohei Harada; Hector R Villarraga; Sunil V Mankad; Ognjen Gajic
Journal:  J Anesth       Date:  2017-01-31       Impact factor: 2.078

4.  The new trials of early goal-directed resuscitation: three-part harmony or disharmony?

Authors:  James A Russell; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2013-08-20       Impact factor: 17.440

Review 5.  Acute kidney injury: the beginning of the end of the dark ages.

Authors:  Pamela D Winterberg; Christopher Y Lu
Journal:  Am J Med Sci       Date:  2012-10       Impact factor: 2.378

Review 6.  [New KDIGO guidelines on acute kidney injury. Practical recommendations].

Authors:  A Zarbock; S John; A Jörres; D Kindgen-Milles
Journal:  Anaesthesist       Date:  2014-07       Impact factor: 1.041

7.  Association of conflicts of interest with the results and conclusions of goal-directed hemodynamic therapy research: a systematic review with meta-analysis.

Authors:  Lina Zhang; Feng Dai; Alexandria Brackett; Yuhang Ai; Lingzhong Meng
Journal:  Intensive Care Med       Date:  2018-08-13       Impact factor: 17.440

8.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

Review 9.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

Review 10.  Control groups in recent septic shock trials: a systematic review.

Authors:  Ville Pettilä; Peter Buhl Hjortrup; Stephan M Jakob; Erika Wilkman; Anders Perner; Jukka Takala
Journal:  Intensive Care Med       Date:  2016-07-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.